
OLD Category: methods
June 6, 2023 / Nat Rev Mol Cell Biol
The technological landscape and applications of single-cell multi-omics
Single-cell multi-omics technologies and methods characterize cell states and activities by simultaneously integrating various single-modality omics methods that profile the transcriptome, genome, epigenome, epitranscriptome, proteome, metabolome and other (emerging) omics.…
June 2, 2023 / Sci Rep
Sample size calculation for a NanoString GeoMx spatial transcriptomics experiment to study predictors of fibrosis progression in non-alcoholic fatty liver disease
Sample size calculation for spatial transcriptomics is a novel and understudied research topic. Prior publications focused on powering spatial transcriptomics studies to detect specific cell populations or spatially variable expression…
May 31, 2023 / Innovation Life
Spatial transcriptomics in cancer research: Opportunities and challenges
Spatial transcriptomics (ST) technologies can be divided into two categories, depending on the strategies used to measure transcripts: imaging-based and sequencing-based technologies. Imaging-based ST technologies employ microscopy to detect transcripts…
May 31, 2023 / Biomark Res
Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications
Multiple myeloma (MM) is a hematological malignancy characterized by clonal proliferation of plasma cells. Although therapeutic advances have been made to improve clinical outcomes and to prolong patients’ survival in…
May 26, 2023 / Hemasphere
Unraveling Heterogeneity in the Aging Hematopoietic Stem Cell Compartment: An Insight From Single-cell Approaches
Specific cell types and, therefore, organs respond differently during aging. This is also true for the hematopoietic system, where it has been demonstrated that hematopoietic stem cells alter a variety…
May 23, 2023 / Front Oncol
Could the tumor-associated microbiota be the new multi-faceted player in the tumor microenvironment?
Microorganisms have been identified in tumor specimens for over a century. It is only in recent years that tumor-associated microbiota has become a rapidly expanding field. Assessment techniques encompass methods…
May 22, 2023 / Front Oncol
Multiomics technologies for comprehensive tumor microenvironment analysis in triple-negative breast cancer under neoadjuvant chemotherapy
Triple-negative breast cancer (TNBC) is one of the most aggressive breast cancer subtypes and is characterized by abundant infiltrating immune cells within the microenvironment. As standard care, chemotherapy remains the…
May 18, 2023 / J Transl Med
Advances in spatial transcriptomics and related data analysis strategies
Spatial transcriptomics technologies developed in recent years can provide various information including tissue heterogeneity, which is fundamental in biological and medical research, and have been making significant breakthroughs. Single-cell RNA…
May 17, 2023 / Methods Mol Biol
High-Plex Spatial Profiling of RNA and Protein Using Digital Spatial Profiler
The rapid emergence of spatial multi-omics technologies in recent years has revolutionized biomedical research. Among these, the Digital Spatial Profiler (DSP, commercialized by nanoString) has become one of the dominant…
May 12, 2023 / Circ Res
Cell-specific mechanisms in the heart of COVID-19 patients
From the onset of the pandemic, evidence of cardiac involvement in acute COVID-19 abounded. Cardiac presentations ranged from arrhythmias to ischemia, myopericarditis/myocarditis, ventricular dysfunction to acute heart failure, and even…
May 9, 2023 / Nucleic Acids Res
vissE.cloud: a webserver to visualise higher order molecular phenotypes from enrichment analysis
Gene-set analysis (GSA) dominates the functional interpretation of omics data and downstream hypothesis generation. Despite its ability to summarise thousands of measurements into semantically interpretable components, GSA often results in…
May 5, 2023 / Trends Cancer
Immune cells in residual disease and recurrence
Tumor recurrence following potentially curative therapy constitutes a major obstacle to achieving cures in patients with cancer. Recurrent tumors frequently arise from a population of residual cancer cells – also…